COVID-19: Epidemiological Study of the Spread of SARS-CoV-2 in the Household of a Person Who Has Had a COVID-19 Disease

NACompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

July 12, 2020

Primary Completion Date

September 30, 2020

Study Completion Date

November 30, 2020

Conditions
Coronavirus Infection
Interventions
DIAGNOSTIC_TEST

COVID-19 IgG / IgM rapid test (whole blood, serum, plasma)

"* The rapid test is performed using a drop of blood obtained at the fingertip (10 microliters) using a lancet.~* The dropper pipette, held vertically, collects the drop of whole blood up to the sample line~* Place 1 drop of whole blood (10 μL in the sample well (S) of the cassette.~* Immediately add 2 drops (80μL) of buffer to the well (B) of the cassette.~* Avoid air bubbles; if there is an air bubble, add a 3rd drop of buffer.~The reading is taken after 10 minutes at most by the healthcare professional under medical supervision.~In case of sepositivity of the rapid test, it may be offered to index cases and adult contacts, a blood sample of 5 ml of blood for a serothèque allowing a characterization of the antibodies and in particular of the neutralizing antibodies."

Trial Locations (1)

75013

Christine KATLAMA, Paris

All Listed Sponsors
lead

Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida

OTHER

NCT04511949 - COVID-19: Epidemiological Study of the Spread of SARS-CoV-2 in the Household of a Person Who Has Had a COVID-19 Disease | Biotech Hunter | Biotech Hunter